Skip to content

Lexeo Therapeutics (LXEO) IPO deck

Lexeo Therapeutics is a genetic medicine company, and part of its focus involves developing treatments and therapies based on genetic medicine.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest